Skip to main content
OpenTrials
Enrolling by invitation

NCT Number: NCT07775053

Efficacy of Tramadol With Ropivacaine for Modified Pectoral Nerve Block in Breast Cancer Surgery

In this study the investigators will compare the post operative opoid consumption for patient undergoing modified radical mastectomy. The patients will be divided into two groups one group will receive modified pectoral nerve block with local anesthetic ropivacaine combined with tramadol and other group will receive pectoral nerve block with ropivacaine only

Enrolling by invitation

Interested in participating?

Request Info

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

20 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dr Faisal Masood teaching Hospital Sargodha

Sargodha, Punjab Province, 40100, Pakistan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female Patients aged 20-70 years
  • Patients scheduled for elective unilateral modified radical mastectomy
  • Patients with ASAI andII physical status.

Exclusion criteria

  • Patients on anticoagulant therapy.
  • Patients with a BMI≥35 kg/m3.
  • Patients with a history of allergy to local anesthetics.
  • Patients with significant neurological or psychiatric disorders.
  • Pregnant patients.

Treatment and study plan

pectoral nerve block

Procedure

One group will receive ropivacaine with tramadol in modified pectoral nerve block

Primary outcomes

  1. Postoperative Pain with visual analogue scale

    Time frame: 24 hrs postoperatively with visual analogue scale

Sponsors and collaborators

Lead sponsor

Sargodha Medical College

Other

Registry information

Official study title

Comparison of Post Operative Analgesia Between 0.25% Ropivacaine and 0.25% Ropivacaine Combined With Tramadol in Ultrasound Guided Modified Pectoral Nerve Block for Patient Undergoing Modified Radical Mastectomy.

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 20, 2026
Registry last updated
Aug 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.